Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44033290HTLV-1ENSG00000178568.16protein_codingERBB4YesNo2066Q15303
TVIS44024746HTLV-1ENSG00000178568.16protein_codingERBB4YesNo2066Q15303
TVIS44044419HTLV-1ENSG00000178568.16protein_codingERBB4YesNo2066Q15303
TVIS44037803HTLV-1ENSG00000178568.16protein_codingERBB4YesNo2066Q15303
TVIS44044418HTLV-1ENSG00000178568.16protein_codingERBB4YesNo2066Q15303
TCGA Plot Options
Drug Information
GeneERBB4
DrugBank IDDB15035
Drug NameZanubrutinib
Target IDBE0004772
UniProt IDQ15303
Regulation Typeinhibitor
PubMed IDs31340982; 31381333
CitationsTam CS, Trotman J, Opat S, Burger JA, Cull G, Gottlieb D, Harrup R, Johnston PB, Marlton P, Munoz J, Seymour JF, Simpson D, Tedeschi A, Elstrom R, Yu Y, Tang Z, Han L, Huang J, Novotny W, Wang L, Roberts AW: Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL. Blood. 2019 Sep 12;134(11):851-859. doi: 10.1182/blood.2019001160. Epub 2019 Jul 24.@@Guo Y, Liu Y, Hu N, Yu D, Zhou C, Shi G, Zhang B, Wei M, Liu J, Luo L, Tang Z, Song H, Guo Y, Liu X, Su D, Zhang S, Song X, Zhou X, Hong Y, Chen S, Cheng Z, Young S, Wei Q, Wang H, Wang Q, Lv L, Wang F, Xu H, Sun H, Xing H, Li N, Zhang W, Wang Z, Liu G, Sun Z, Zhou D, Li W, Liu L, Wang L, Wang Z: Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase. J Med Chem. 2019 Sep 12;62(17):7923-7940. doi: 10.1021/acs.jmedchem.9b00687. Epub 2019 Aug 19.
GroupsApproved; Investigational
Direct ClassificationDiphenylethers
SMILESNC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL3936761